Polyribonucleotides for cancer therapy: summary and recommendations for further research.
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002266:Carboxymethylcellulose Sodium / Q000627:therapeutic use / Q000031:analogs & derivatives; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D006801:Humans; D051379:Mice; D009369:Neoplasms / Q000188:drug therapy* / Q000276:immunology; D011070:Poly I-C / Q000627:therapeutic use; D011107:Polylysine / Q000627:therapeutic use / Q000031:analogs & derivatives; D011131:Polyribonucleotides / Q000627:therapeutic use*; D012107:Research Design
D000970:Antineoplastic Agents; D011131:Polyribonucleotides; D011107:Polylysine; C019531:poly ICLC; D002266:Carboxymethylcellulose Sodium; D011070:Poly I-C